Episodes
-
Reporting Season: Scorecards and insights – Tom Sartor, Equity Strategist
February was a stunning season. Beats strongly overwhelmed misses by a record margin versus recent history. February was broadly a story of cyclicals outperforming overly-fearful valuations similar to August. Particularly impressive were Large-caps and domestic cyclicals as expected (Retail,...
-
Reporting Season Preview: Healthcare - Dr. Derek Jellinek, Senior Analyst
Morgans Senior Analyst, Dr. Derek Jellinek, discusses the Healthcare Sector ahead of the February 2020 Reporting Season. In this update, Derek also highlights his thoughts on ResMed (ASX:RMD), CSL (ASX:CSL) and Ramsay Healthcare (ASX:RHC), considering their recent short-term price decline. Check...
-
Reporting Season: Aurizon (ASX:AZJ) - Andrew Harding, Managing Director
Andrew Harding Managing Director of Aurizon (ASX:AZJ) discusses company results for 1H21 with the Morgans network. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram:...